Phenolphthalein laxatives ban proposed by FDA; Ex-Lax with senna to debut.

This article was originally published in The Tan Sheet

01 Sep 1997
News

The Tan Sheet

Executive Summary

NOVARTIS EX-LAX REFORMULATED WITH SENNA TO BE ON SHELVES IN 60 DAYS, the company said in a state-ment issued Aug. 29 responding to FDA's proposed rule banning the OTC sale of phenolphthalein. Phenolphthalein is the active ingredient in many products in Novartis' Ex-Lax line of laxatives.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Industries
Consumer
Subjects
OTC Drugs

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Consumer OTC Drugs

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS087495

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS087495

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Phenolphthalein laxatives ban proposed by FDA; Ex-Lax with senna to debut.

News

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert